{"acquisitions":[],"changes":[{"companyHref":"/c/pearlbio-com","date":"2026-09-27","documentUrl":null,"domain":"pearlbio.com","fact":"latest round","name":"Pearl Bio","new":{"amountUsd":1000000,"date":"2024-01-01","lead":null,"type":"series-a"},"old":{"amountUsd":1000000,"date":"2024-01-01","lead":"khosla","type":"series-a"},"publisher":"vc-portfolio","reason":null,"retrievedAt":"2026-05-07","slug":"pearlbio-com","status":"attributed","url":"https://whoraisedwhat.com/c/pearlbio-com"},{"companyHref":"/c/pearlbio-com","date":"2026-09-27","documentUrl":"https://www.khoslaventures.com/portfolio","domain":"pearlbio.com","fact":"provenance:investor:khosla","name":"Pearl Bio","new":{"publisher":"Khosla Ventures","status":"sourced","url":"https://www.khoslaventures.com/portfolio"},"old":{"publisher":null,"status":"unknown","url":null},"publisher":"Khosla Ventures","reason":null,"retrievedAt":"2026-09-27","slug":"pearlbio-com","status":"sourced","url":"https://whoraisedwhat.com/c/pearlbio-com"}],"country":"US","description":"Pearl Bio uses genome and ribosome engineering to manufacture biologics with non-canonical amino acids and novel chemistries. It serves pharma partners looking for protein-drug formats outside what natural ribosomes can build. A $1B collaboration with Merck for engineered cancer biologics is the kind of platform deal narrow-spectrum protein-engineering shops rarely attract.","domain":"pearlbio.com","employees":null,"founded":2020,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":["khosla"],"lat":38.895098,"lng":-77.036385,"location":"Washington, DC","multiples":[],"name":"Pearl Bio","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":1000000,"connectionsAmong":[],"currency":"USD","date":"2024-01-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"pearlbio-com-2024-01-01-series-a","source":{"fact":"round","publisher":"vc-portfolio","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"series-a","url":null}],"slug":"pearlbio-com","sources":[{"fact":"round","publisher":"vc-portfolio","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"pearlbio.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://pearlbio.com"},{"fact":"description","publisher":"pearlbio.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://pearlbio.com"},{"fact":"investor:khosla","publisher":"Khosla Ventures","retrievedAt":"2026-09-27","status":"sourced","url":"https://www.khoslaventures.com/portfolio"}],"stage":"series-a","stockCard":{"asOf":"2026-11-09","facts":[{"id":"investor:{\"actorKind\": \"investor\", \"name\": \"Khosla Ventures\", \"role\": \"portfolio\", \"slug\": \"khosla\", \"sources\": [{\"publisher\": \"Khosla Ventures\", \"retrievedAt\": \"2026-09-27\", \"status\": \"sourced\", \"url\": \"https://www.khoslaventures.com/portfolio\"}]}","kind":"investor","sources":[{"publisher":"Khosla Ventures","retrievedAt":"2026-09-27","status":"sourced","url":"https://www.khoslaventures.com/portfolio"}],"text":"Pearl Bio was listed in Khosla Ventures's portfolio, recorded 2026-09-27."}],"generatedAt":"2026-11-09","investors":[{"actorKind":"investor","name":"Khosla Ventures","role":"portfolio","slug":"khosla","sources":[{"publisher":"Khosla Ventures","retrievedAt":"2026-09-27","status":"sourced","url":"https://www.khoslaventures.com/portfolio"}]}],"state":"insufficient-evidence","tldr":[]},"techStack":["Cloudflare","All in One SEO 4.4.3","All in One SEO Pack 4.4.3","Kinsta","Google Analytics","Google Tag Manager","Font Awesome","jQuery Migrate 3.4.1","Elementor 3.13.4","Elementor Addon Elements 1.1.0","particles.js","DoubleClick Floodlight"],"totalRaisedUsd":1000000,"traction":[],"updatedAt":"2026-05-07","valuations":[]}